Newsroom

News & Media

Prometheus Biosciences Appoints Dr. Thierry Dervieux as Chief Development Officer

Prometheus Biosciences, Inc., Enters Into Multi-Target Strategic Collaboration with Takeda to Develop Targeted Therapies for Inflammatory Bowel Disease

Prometheus Biosciences Strengthens Executive Management Team with New Appointments

Precision IBD Announces Next Phase Of Growth: Appoints Mark C. McKenna As President And Chief Executive Officer, Completes Name Change To Prometheus Biosciences, Inc.

In the News

XCONOMY – Prometheus Bio Taps Thierry Dervieux as Chief Development Officer

XCONOMY – Precision IBD Rebrands as Prometheus and Strikes R&D Deal with Takeda

Events & Presentations

Coming Soon